The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: Relationship with insulin resistance and IGF-I

Minerva Ginecologica

Volumn 66, Issue 2, 2014, Pages 209-218

  Shokeir, T ^a   El Kannishy, G ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Insulin resistance.; Laparoscopy; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; TRIACYLGLYCEROL; LIPID;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FERTILE PERIOD; FLOW MEDIATED DILATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LAPAROSCOPIC OVARIAN DRILLING; LAPAROSCOPIC SURGERY; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PILOT STUDY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; BLOOD FLOW; CASE CONTROL STUDY; FOLLOW UP; INFERTILITY, FEMALE; LAPAROSCOPY; METABOLISM; OVARY; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PROCEDURES; REGRESSION ANALYSIS; VASCULAR ENDOTHELIUM; VASCULARIZATION; YOUNG ADULT;

ADULT; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LAPAROSCOPY; LIPIDS; OVARY; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 84902586213     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Moran LJ, Cameron JD, Strauss BJ, Teede HJ. Vascular function in the diagnostic categories of polycystic ovary syndrome. Hum Reprod 2011;26:2192-9.
2. Peitsidis P, Agrawal R. Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reprod Biomed Online 2010;20:444-52.
3. Kaya MG, Gunebakmaz O, Zencir C, Yilmazsoy A, Karadag M, Topsakal R et al. An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome. Fertil Steril 2010;94:2402-5.
4. Hudecova M, Holte J, Olovsson M, Lind L, Poromaa IS. Endothelial function in patients with polycystic ovary syndrome: a long-term follow-up study. Fertil Steril 2010;94:2654-8.
5. Naka KK, Kalantaridou SN, Kravariti M, Bechlioulis A, Kazakos N, Calis KA et al. Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril 2011;95:203-9.
6. Mak W, Dokras A. Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 2009;35:613-20.
7. Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric 2009;12(Suppl 1):22-5.
8. Mather K, Verma S, Corenblum B, Anderson T. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metabol 2000;85:1851-6. (Pubitemid 32269288)
9. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997;29:691-9. (Pubitemid 27097972)
10. Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Fertil Steril 2007;88:139-44. (Pubitemid 47007688)
11. Diamanti-Kandarakis E, Piperi C, Spina J, Argyrakopoulou G, Papanastasiou L et al. Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens) 2006;5:17-34.
12. Xu LZ, Li R, Sun ZJ, Han DW, Qiu DS. The relationship between leptin, insulin-like growth factor-1 (IGF-1) and hyperinsulinemia of patients with polycystic ovarian syndrome. Sichuan Da Xue Xue Bao Yi Xue Ban 2006;37:882-5. (Pubitemid 44862260)
13. Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 2004;19:125-33. (Pubitemid 39486898)
14. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends Endocrinol Metab 2010;21:245-54.
15. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139:761-76. (Pubitemid 38139234)
16. McCallum RW, Hamilton CA, Graham D, Jardine E, Connell JM, Dominiczak AF. Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats. J Hypertens 2005;23:351-8. (Pubitemid 40279638)
17. Göke B, Fehmann HC. Insulin and insulin-like growth factor-I: their role as risk factors in the development of diabetic cardiovascular disease. Diabetes Res Clin Pract 1996;30(Suppl):93-106. (Pubitemid 126352583)
18. Abbas A, Grant PJ, Kearney MT. Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Rev Cardiovasc Ther 2008;6:1135-49.
19. Xu LZ, Li R, Sun ZJ, Han DW, Qiu DS. The relationship between leptin, insulin-like growth factor-1 (IGF-1) and hyperinsulinemia of patients with polycystic ovarian syndrome. Sichuan Da Xue Xue Bao Yi Xue Ban 2006;37:882-5. (Pubitemid 44862260)
20. Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 2004;19:125-33. (Pubitemid 39486898)
21. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-45. (Pubitemid 30180890)
22. Panza J, García C, Kilcoyne CM, Quyyumi A, Cannon R. Impaired endothelium-dependent vasodilation in patients with essential hypertension, evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995;91:1732-8.
23. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996;137:1798-803. (Pubitemid 26133956)
24. Nader S. Ovulation induction in women with polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:438-9. (Pubitemid 46808740)
25. Palomba S, Falbo A, Battista L, Russo T, Venturella R, Tolino A et al. Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol 2010;202:577.e1-8.
26. Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA et al. Society of Obstetricians and Gynecologists of Canada. Ovulation induction in polycystic ovary syndrome. J Obstet Gynaecol Can 2010;32:495-502. Erratum in: J Obstet Gynaecol Can 2010;32:1027.
27. Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G, Greenblatt EM. J Clin Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. Endocrinol Metab 1999;84:4278-82. (Pubitemid 30644230)
28. El Behery MM, Diab AE, Mowafy H, Ebrahiem MA, Shehata AE. Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3-dimensional power Doppler. Int J Gynaecol Obstet 2011;112:119-21.
29. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
30. Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager MA et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Clin Endocrinol Metab 2005,90:5088-95.
31. El-Kannishy G, Kamal S, Mosa A, Saleh O, El-Badrawy A, El-Farahaty R et al. Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance. Obes Res Clin Pract 2009;4:e49-e56.
32. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Pastorino AM et al. Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 1998,16(12 Pt 2):1913-9.
33. Dasanu CA, Clark BA 3rd, Ichim TE, Alexandrescu DT. Polycystic ovary syndrome: focus on platelets and prothrombotic risk. South Med J 2011;104:174-8.
34. Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Fertil Steril 2007;88:139-44. (Pubitemid 47007688)
35. Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe BM et al. Progesterone receptors in the human heart and great vessels. Lab Invest 1988;59:353-6.
36. Mårin P, Holmäng S, Jönsson L, Sjöström L, Kvist H, Holm G et al. The effects of testosterone treatment on body composition and metabolism in middLeaged obese men. Int J Obes Relat Metab Disord 1992;16:991-7. (Pubitemid 23010023)
37. Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2699-705. (Pubitemid 28493763)
38. Naka KK, Kalantaridou SN, Bechlioulis A, Kravariti M, Kazakos N, Katsouras CS et al. Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study. Hum Reprod 2011;26:2192-9.
39. Tarkun I, Arslan BC, Cantürk Z, Türemen E, Sahin T, Duman C. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 2004;89:5592-6. (Pubitemid 39518445)
40. Studen KB, Sebestjen M, Pfeifer M, Prezelj J. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. Eur J Endocrinol 2011;164:389-95.